Skip to main content

Advertisement

ADVERTISEMENT

Robert Abraham, MD, FSIR, FRCPC, Dalhousie University
Conference Coverage
04/18/2024

Featuring Robert Abraham, MD, FSIR, FRCPC

Featuring Robert Abraham, MD, FSIR, F...
At the 2024 SIR Annual Meeting, Robert Abraham, MD, FSIR, FRCPC, presented safety and efficacy results from a trial evaluating the use of multimodal imageable glass Y90 microspheres (Eye90 microspheres) for radioembolization for patients with...
At the 2024 SIR Annual Meeting, Robert Abraham, MD, FSIR, FRCPC, presented safety and efficacy results from a trial evaluating the use of multimodal imageable glass Y90 microspheres (Eye90 microspheres) for radioembolization for patients with...
At the 2024 SIR Annual Meeting,...
04/18/2024
IO Learning
Kevin P. Henseler, MD, FACR, Midwest Radiology
Conference Coverage
04/16/2024

Featuring Kevin P. Henseler, MD, FACR

Featuring Kevin P. Henseler, MD, FACR...
Kevin P. Henseler, MD, FACR, discusses real-world experience with a unique shear-thinning hydrogel embolic material.
Kevin P. Henseler, MD, FACR, discusses real-world experience with a unique shear-thinning hydrogel embolic material.
Kevin P. Henseler, MD, FACR,...
04/16/2024
IO Learning
Daniel B. Brown, MD, FSIR
Videos
04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR,...
04/12/2024
IO Learning
Qian (Clark) Yu, MD, University of Chicago
Conference Coverage
04/12/2024

Featuring Qian (Clark) Yu, MD

Featuring Qian (Clark) Yu, MD
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting,...
04/12/2024
IO Learning
AJ Gunn, MD, University of Alabama at Birmingham
Videos
04/11/2024

Featuring AJ Gunn, MD

Featuring AJ Gunn, MD
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting, AJ Gunn, MD, University of Alabama at Birmingham, discussed treatment for patients with central renal tumors.
At the 2024 SIR Annual Meeting,...
04/11/2024
IO Learning
Steven Ramen, MD, University of California, Los Angeles
Conference Coverage
04/08/2024

Featuring Steven Raman, MD

Featuring Steven Raman, MD
At the 2024 SIR Annual Meeting, Steve Raman, MD, presented 5-year follow-up data from a trial evaluating the use of transurethral ultrasound ablation among patients with prostate cancer.
At the 2024 SIR Annual Meeting, Steve Raman, MD, presented 5-year follow-up data from a trial evaluating the use of transurethral ultrasound ablation among patients with prostate cancer.
At the 2024 SIR Annual Meeting,...
04/08/2024
IO Learning
Andrew Kennedy, MD, Sarah Cannon Research Institute
Conference Coverage
04/03/2024

Featuring Andrew Kennedy, MD

Featuring Andrew Kennedy, MD
At the 2024 SIR Annual Meeting, Andrew Kennedy, MD, discusses the utilization of imageable glass Y90 microspheres in radioembolization for patients with hepatocellular carcinoma.
At the 2024 SIR Annual Meeting, Andrew Kennedy, MD, discusses the utilization of imageable glass Y90 microspheres in radioembolization for patients with hepatocellular carcinoma.
At the 2024 SIR Annual Meeting,...
04/03/2024
IO Learning

Advertisement

Advertisement

Advertisement